Our finding that overexpressing CCT2 promoted the proliferation of breast cancer and breast epithelial cells is among the first to demonstrate that an increase in cancer cell growth and upregulation of select CDKs as well as other CCT subunits resulted from overexpressing this single CCT subunit. This evidence concerns the gene FLVCR2 and breast carcinoma.